Pre-recorded example

These results are captured from a real systematic-review run and don't change based on the query-builder inputs.

HMA + Venetoclax vs Intensive Induction in Older Adults with AML

In older adults with newly diagnosed acute myeloid leukemia (AML) considered candidates for antileukemic therapy, how does conventional induction and post-remission therapy compared with hypomethylating agent (HMA) plus venetoclax affect remission outcomes and 5-year survival?

Job ID: 2950_in_older_adults_with_user

Back to Query Builder

Pipeline Execution

Track the progress of your systematic review through the automated workflow

Pipeline Steps

Loading workflow data...

Workflow execution for job: 2950_in_older_adults_with_user

Auto-refreshing every 3 seconds|Last updated: 4:47:28 PM